- Home
- NRXP vs OKYO Comparison
NRXP vs OKYO Comparison
Compare NRXP & OKYO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NRXP
- OKYO
- Stock Information
- Founded
- NRXP 2015
- OKYO 2007
- Country
- NRXP United States
- OKYO United Kingdom
- Employees
- NRXP N/A
- OKYO N/A
- Industry
- NRXP Biotechnology: Pharmaceutical Preparations
- OKYO Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- NRXP Health Care
- OKYO Health Care
- Exchange
- NRXP Nasdaq
- OKYO Nasdaq
- Market Cap
- NRXP 32.6M
- OKYO 37.0M
- IPO Year
- NRXP N/A
- OKYO 2022
- Fundamental
- Price
- NRXP $3.27
- OKYO $2.45
- Analyst Decision
- NRXP Strong Buy
- OKYO Strong Buy
- Analyst Count
- NRXP 4
- OKYO 1
- Target Price
- NRXP $28.50
- OKYO $7.00
- AVG Volume (30 Days)
- NRXP 298.7K
- OKYO 215.4K
- Earning Date
- NRXP 08-13-2025
- OKYO 08-12-2025
- Dividend Yield
- NRXP N/A
- OKYO N/A
- EPS Growth
- NRXP N/A
- OKYO N/A
- EPS
- NRXP N/A
- OKYO N/A
- Revenue
- NRXP N/A
- OKYO N/A
- Revenue This Year
- NRXP N/A
- OKYO N/A
- Revenue Next Year
- NRXP N/A
- OKYO N/A
- P/E Ratio
- NRXP N/A
- OKYO N/A
- Revenue Growth
- NRXP N/A
- OKYO N/A
- 52 Week Low
- NRXP $1.10
- OKYO $0.81
- 52 Week High
- NRXP $6.01
- OKYO $3.11
- Technical
- Relative Strength Index (RSI)
- NRXP 66.15
- OKYO 58.01
- Support Level
- NRXP $2.90
- OKYO $2.05
- Resistance Level
- NRXP $3.61
- OKYO $2.49
- Average True Range (ATR)
- NRXP 0.28
- OKYO 0.31
- MACD
- NRXP -0.03
- OKYO -0.01
- Stochastic Oscillator
- NRXP 64.59
- OKYO 44.44
About NRXP NRX Pharmaceuticals Inc.
NRX Pharmaceuticals Inc is a clinical-stage, small-molecule pharmaceutical company that develops and plans to distribute novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. It has announced the commercialization of ZYESAMI (Aviptadil), an application for COVID-related respiratory failure. The company is also developing NRX-100/101, the first sequential drug regimen for bipolar depression in patients with acute suicidal ideation and behavior.
About OKYO OKYO Pharma Limited
OKYO Pharma Ltd is a biopharmaceutical company. The company is developing therapeutics to improve the lives of patients with inflammatory eye diseases and chronic pain. It offers solutions for various diseases such as Dry Eye Disease, Non-infectious Anterior Uveitis, Allergenic Conjunctivitis, Chronic Pain, and Ocular Pain.